Key points are not available for this paper at this time.
This article covers procedures for transitioning to the common market of the Eurasian Economic Union (EAEU), with a focus on low-margin yet high-demand medicines, including herbal medicinal products. First, the article analyses applicant engagement in aligning the dossiers for nationally authorised medicinal products with the requirements of the EAEU authorisation procedures. Then, the article describes the legislative changes introduced to ease authorisation requirements. Finally, the author provides recommendations for applicants.
Е. М. Рычихина (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: